stockrow
Friday 6 November 2026
Export AEMD’s income statement to Excel — free account
Aethlon Medical, Inc.
AEMD Healthcare Medical Devices
Aethlon Medical, Inc.’s revenue for fiscal 2023 (year ended March 2023) was $574,200.00, up 95.2% from fiscal 2022.
- EPS
- +90.5%
- Free cash flow
- −11.1%
Quarter to June 2026, against a year earlier
5.47
0.16
+3.01%
Follow AEMD
Alert me
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Piotroski F-Score |
2 | 4 | 4 | 5 | 3 | 4 | 5 | — | — | — |
Altman Z-Score |
(73.32) | (13.49) | (34.35) | (12.93) | (6.48) | (4.80) | (10.75) | — | — | — |
P/S ratio |
32.88 | 31.28 | 42.25 | 7.49 | 19.04 | 73.45 | 10.60 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(196.52) | (37.69) | (88.47) | (24.55) | (29.00) | (12.62) | (19.51) | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/Operating CF |
(20.57) | (16.50) | (11.46) | (3.38) | (10.88) | (6.97) | (2.65) | — | — | — |
Beneish M-Score |
— | — | — | — | (3.40) | (1.77) | — | — | — | — |
P/B ratio |
32.95 | 2.78 | 6.97 | 0.59 | 2.62 | 1.27 | 0.52 | — | — | — |
Price to Tangible BV |
38.44 | 2.82 | 7.18 | 0.59 | 2.64 | 1.27 | 0.52 | — | — | — |
EV/Sales |
31.14 | 19.86 | 34.45 | (4.47) | 12.01 | 18.38 | (7.96) | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.56 | 0.00 | 0.00 | 0.48 | — | — | — |
EV/Operating CF |
(5.30) | (2.73) | (3.04) | 0.63 | (2.27) | (0.55) | 0.56 | — | — | — |
EV/FCF |
(5.27) | (2.71) | (3.03) | 0.61 | (2.25) | (0.53) | 0.51 | — | — | — |
Quick Ratio |
2.55 | 14.75 | 2.10 | 9.19 | 7.28 | 9.43 | 9.66 | 2.97 | 2.90 | 3.47 |
Current Ratio |
2.61 | 15.13 | 2.21 | 9.40 | 7.53 | 9.95 | 10.03 | 3.40 | 3.13 | 3.85 |
Net Debt/EBITDA |
0.18 | 1.35 | 0.65 | 1.64 | 1.26 | 1.66 | 1.25 | 0.44 | 0.61 | 0.72 |
Debt/Assets |
30.07% | 11.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.87 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.18 | 0.03 | 0.04 | 0.09 | 0.06 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.48 | 0.69 | 0.69 | 0.82 | 0.86 | 0.94 | 0.87 | 0.83 | 0.57 | 0.98 |
Capex/Depreciation |
(0.06) | (0.09) | 0.00 | (2.68) | (1.60) | (2.26) | (3.91) | (0.70) | 0.00 | (0.01) |
Interest Coverage |
(20.04) | (13.36) | (27.21) | (109.41) | (4,932.19) | — | (1,081.69) | — | (924.89) | (506.50) |
| (693.69%) | (171.38%) | (148.70%) | (110.12%) | (84.94%) | (79.25%) | (75.06%) | (117.21%) | (245.88%) | (142.89%) | |
| (341.96%) | (125.12%) | (107.97%) | (87.85%) | (74.91%) | (69.24%) | (65.15%) | (94.80%) | (171.58%) | (104.46%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,399.70%) | (2,435.36%) | 0.00% | 0.00% |
Return on Tangible Assets |
(717.07%) | (83.77%) | (279.02%) | (69.94%) | (86.31%) | (62.10%) | (81.67%) | (225.61%) | (283.24%) | (159.65%) |
Average Days of Receivables |
0.00 | 182.50 | 0.00 | 116.03 | 82.57 | 158.80 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Selling, General and Administrative Expense of Revenue |
1,655.29% | 3,329.34% | 2,712.80% | 1,012.03% | 1,297.31% | 3,642.11% | 2,172.22% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.05 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
557.59% | 842.78% | 574.48% | 129.81% | 118.25% | 255.13% | 183.19% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.02 | 0.35 | 0.14 | 1.63 | 0.37 | 0.73 | 1.62 | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
(28.83%) | (34.98%) | (38.18%) | (123.65%) | (32.02%) | (47.95%) | (156.86%) | — | — | — |
Free Cash Flow Yield |
(17.95%) | (23.43%) | (26.95%) | (97.76%) | (28.02%) | (46.82%) | (146.72%) | — | — | — |
Revenue per Share |
3,030.14 | 748.00 | 765.33 | 722.44 | 219.70 | 79.51 | 112.59 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(27,093.51) | (19,553.50) | (14,311.33) | (5,775.11) | (2,254.97) | (2,639.78) | (2,059.82) | (1,607.90) | (245.05) | (51.92) |
Capex per Share |
(126.74) | (124.00) | 0.00 | (168.56) | (19.97) | (94.38) | (184.92) | (39.83) | 0.00 | (0.03) |
Free Cash Flow per Share |
(27,220.25) | (19,677.50) | (14,311.33) | (5,943.67) | (2,274.93) | (2,734.16) | (2,244.75) | (1,647.73) | (245.05) | (51.94) |
Cash per Share |
12,053.32 | 34,870.50 | 12,760.33 | 10,672.00 | 3,287.20 | 4,614.16 | 2,849.59 | 863.81 | 176.32 | 37.29 |
Shareholders Equity per Share |
4,601.24 | 30,164.00 | 7,663.67 | 10,308.22 | 3,097.90 | 4,592.27 | 2,953.76 | 915.29 | 164.21 | 36.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4,601.24 | 30,164.00 | 7,663.67 | 10,308.22 | 3,097.90 | 4,592.27 | 2,953.76 | 915.29 | 164.21 | 36.25 |
Free Cash Flow |
(3.52) | (3.94) | (4.29) | (5.35) | (6.82) | (10.12) | (11.45) | (10.38) | (7.65) | (7.00) |
Working Capital |
0.99 | 6.75 | 2.21 | 8.97 | 8.98 | 16.33 | 13.59 | 4.40 | 4.05 | 4.12 |
Capital Expenditures |
(0.02) | (0.02) | — | (0.15) | (0.06) | (0.35) | (0.94) | (0.25) | — | 0.00 |
Net Current Asset Value |
0.47 | 5.91 | 2.21 | 8.93 | 8.98 | 15.73 | 12.65 | 3.75 | 3.71 | 4.12 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.49 | — | — | — |
Capex to Sales |
0.04 | 0.17 | 0.00 | 0.23 | 0.09 | 1.19 | 1.64 | 0.00 | — | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
8.66 | 10.19 | 25.30 | 0.40 | 0.23 | 0.35 | 0.21 | 0.35 | 0.50 | 0.91 |
Cash ROIC |
(131.71%) | (28.42%) | (70.07%) | (28.33%) | (35.63%) | (29.70%) | (38.68%) | (92.62%) | (71.96%) | (70.64%) |
Accounts Receivable Turnover |
0.00 | 1.09 | 0.00 | 4.62 | 3.70 | 2.12 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | 0.14 | — | 0.14 | 0.18 | 0.14 | — | — | — | — |
Average Payables |
0.36 | 0.30 | 0.13 | 0.21 | 0.31 | 0.42 | 0.47 | 0.61 | 0.66 | 0.46 |
Average Assets |
2.13 | 4.54 | 5.74 | 7.26 | 10.53 | 15.04 | 18.46 | 12.88 | 7.80 | 6.85 |
Average Common Equity |
1.05 | 3.31 | 4.17 | 5.79 | 9.29 | 13.14 | 16.03 | 10.42 | 5.44 | 5.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026